Nano vaccines for T. gondii Ribosomal P2 Protein With Nanomaterials as a Promising DNA Vaccine Against Toxoplasmosis

Caused by Toxoplasma gondii, toxoplasmosis has aroused great threats to public health around the world. So far, no effective vaccine or drug is commercially available, and the demands for a safe and effective therapeutic strategy have become more and more urgent. In the current study, we constructed...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, ZhengQing, He, Ke, Cao, WanDi, Aleem, Muhammad Tahir, Yan, RuoFeng, Xu, LiXin, Song, XiaoKai, Li, XiangRui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899214/
https://www.ncbi.nlm.nih.gov/pubmed/35265084
http://dx.doi.org/10.3389/fimmu.2022.839489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899214/
https://www.ncbi.nlm.nih.gov/pubmed/35265084
http://dx.doi.org/10.3389/fimmu.2022.839489

Ejemplares similares